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Abstract
A novel hepatitis B virus (HBV) strain (W29) was isolated from serum samples in the northwest of China. Phylogenetic and
distance analyses indicate that this strain is grouped with a series of distinct strains discovered in Vietnam and Laos
that have been proposed to be a new genotype I. TreeOrderScan and GroupScan methods were used to study the
intergenotype recombination of this special group. Recombination plots and tree maps of W29 and these putative
genotype I strains exhibit distinct characteristics that are unexpected in typical genotype C strains of HBV. The amino acids
of P gene, S gene, X gene, and C gene of all genotypes (including subtypes) were compared, and eight unique sites were
found in genotype I. In vitro and in vivo experiments were also conducted to determine phenotypic characteristics between
W29 and other representative strains of different genotypes obtained from China. Secretion of HBsAg in Huh7 cells is
uniformly abundant among genotypes A, B, C, and I (W29), but not genotype D. HBeAg secretion is low in genotype I (W29),
whose level is close to genotype A and much lower than genotypes B, C, and D. Results from the acute hydrodynamic
injection mouse model also exhibit a similar pattern. From an overview of the results, the viral markers of W29 (I1) in Huh7
cells and mice had a more similar level to genotype A than genotype C, although the latter was closer to W29 in distance
analysis. All evidence suggests that W29, together with other related strains found in Vietnam and Laos, should be classified
into a new genotype.
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Introduction
The hepatitis B virus (HBV) is globally distributed, infecting
approximately one-third of the world’s human population.
Genotypes of HBV were first suggested by Okamoto who noted
that 4 HBV genomes of different genotype differed by more than
8% [1]. Then threshold had been used for separation of the
different genotypes. With more and more HBV complete sequence
discovered, a threshold of 7.5% was suggested after a phylogenetic
analysis and pairwise comparison of 670 complete genomes [2].
Norder also suggested to take the first branch (S gene) in an
alignment to assign genotypes [3]. Presently, eight genotypes of
HBV, designated with A to H, have been recognized [4,5,6]. Some
of the genotypes could be mapped to a special geographic
distribution but others could not. Consider not varying phrasing so
often: Genotype A is prevalent in sub-Saharan Africa, North
America and Europe; B/C, in Asia; E, in Africa; and F/H, in
Central and South America. Genotypes D/G, on the other hand,
seem to be scattered worldwide. In addition to these acknowledged
genotypes, there’re putative genotypes that could not classify into
those group above. Such variants include genotype I [5,7] and J
[8]. Prior to the definition of genotypes, HBV stains can be divided
into 9 serotypes, designated as ayw1, ayw2, ayw3, ayw4, ayr, adw2,
adw4q2, adrq+, and adrq2, according to the different serological
analysis results of surface antigen [9,10]. Although there are some
complicated relationships between genotypes and serotypes in
HBV, increasing evidence shows that genotypes play a greater role
in determining the clinical severity and development of chronic
infection [11]. Furthermore, the occurrence of HBeAg negative
chronic hepatitis B is also genotype-specific related [11].
The first HBV viral particles were produced in vitro through
transfecting cultured cells with a linear tandem dimer of HBV
[12]. Virions thus produced are morphologically and virologically
indistinguishable from the authentic virion [13], and can infect
chimpanzees [14]. The method was supplemented by the creation
of a a modified, extended genome (,1.3 fold) for transfection
which could be transcribed into overlength pregenomic and
precore mRNAs, providing an in vitro model for studying HBV
infections. In vivo studies had been hampered by a lack of suitably
small and well-characterized animals. Eventually, a mouse model
of acute HBV infection based on hydrodynamic injection and
supporting transitory HBV replication was successfully developed.
This model allowed the examination of HBV dynamics in a tightly
controlled in vivo system [15,16].
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northwest of China. Phylogenetic analysis indicates that this strainis
grouped with a series of distinct strains discovered in Vietnam and
Laos [7,17]. The latter have been proposed to be classified as a new
genotype. A new analysis method was adopted to compare the
recombination of W29 with the putative new genotype I strains, as
well as other known genotypes. The methods TreeOrderScan and
GroupScan were first implemented by Simmond [18] who designed
them to identify independent intergenotype recombinants of HBV
using a series of novel phylogenetic and bioinformatics analysis
methods. We compared the recombination plot of W29 with that of
the putative new genotype I strains, and other known genotypes as
well, and found that W29 and the genotype I strains exhibit some
distinct characteristics which are unexpected in the regular
genotype C strains. The amino acids sequences of P, S, X and C
gene of all genotypes (including subtypes) were compared to
illustrate some unique sites in genotype I. In vitro and in vivo
experiments were also conducted to compare phenotypic charac-
teristics between W29 and other genotypes obtained from China.
All evidence suggests that the W29, together with other related




The study was approved by the Human Subject Committees at
You An Hospital in Beijing, Xi Jing Hospital in Xi’an and Xiamen
Centers for Disease Control. Written informed consent was
obtained from all subjects.
Serum Sample
The W29 case was a 23-year-old female asymptomatic HBV
carrier who had never left the mainland and was living in Xi’an in
the northwest China. The W29 serum sample was obtained when
she received her annual checkup at the hospital in 2006. Serum
samplesofgenotypesAeandBa(N10andC4371,respectively)were
obtained from two HBV carriers living in Fujian province in
southeast China. The sample of genotype C1 (Y1021) was obtained
from a carrier in Beijing innorthernChina. The sampleof genotype
D1 (Y10) was obtained from a carrier in Xi’an in northwest China.
All five sera were HBeAg-positive with detectable levels of HBV
DNA,andwithouttheprecore G1896Aorcore promoter A1762T/
G1764A mutations that may affect HBeAg expression and viral
replication.
HBV Full-Length Genome Sequencing
HBV DNA was extracted from 100 mL of serum using QIAamp
DNA blood kits (QIAGEN, Hilden, Germany). Complete HBV
genomes were amplified by a ‘‘hot-start’’ polymerase chain
reaction using the previously reported method [19]. The amplified
fragments (21825,+1821) were sequenced on an ABI Prism
3130X automatic genetic analyzer, then inserted into pGEM-T
Easy Vector (Takara, Dalian, China) and cloned in DH5a
competent cells. The clones which shared consensus sequences
with the PCR-product were used to construct 1.35-fold genome
plasmids.
Reference Sequences
All available complete genome sequences of HBV were down-
loaded from GenBank at April 2009 with identical entries
excluded. Multiple alignment was done with ClustalX2 under
default settings. Subsequent sequence manipulation was carried
out in the Simmonic sequence editor package [18] (available from
http://www.polio.vir.gla.ac.uk). To make the sequence set most
representative and informative in terms of phylogeny, the most
related sequences were first removed from the dataset with all
pairwise distance scan. Genotype information was extracted from
the GenBank definition, noted automatically and each known
sequence was tagged. In this way, recombinant sequences were
removed. Nearly two-thirds of all sequences were assigned with a
genotype tag, and these were designated as set A. The remainder
were temporarily designated as set B. GroupScan Analysis
(described below) using the known set A for each sequence in
Set A and B was carried out by batch command. With this self-
optimization method, potential recombinant forms in set A were
picked out according to the output plot of GroupScan and non-
recombinant forms in set B were recruited into the dataset. For
new sequences added, pairwise distance scan was carried out again
to exclude the most related sequences and the final dataset
contained 322 sequences with genotype tag as A-H and
Chimpanzee. Subtype information was extracted from related
articles and by further phylogenic analysis. All aligned reference
sequences with subtype tags were then truncated and translated
into P, X, C and S amino acid sequences. Consensus sequences of
each sub-genotype group of HBV were concluded first. This was
done by examining every nucleotide position of all the aligned
sequences in one group for a most abundant one. Then these
consensus sequences were put together and mark with different
colors using MS Excel software to screen for the unique site in
each subtype.
Phylogenetic and Recombination Analysis
Our newly discovered strain W29, together with three sequences
described as ‘aberrant HBV Vietnamese strains’ (AB231908,
AF241408, and AF241409) [20] and the other two sequences from
Laos (FJ023661, FJ023663) [17] for comparison were selected for
phylogenetic and recombination analysis. Distance Calculation
within predefined groups was done with the MEGA4 package [21].
A Tree containing these strains and the reference sequences as
described above was constructed by neighbor-joining with Maxi-
mum Composite Likelihood corrected distances in the MEGA4
package [21], using 500 bootstrap replicates. Nucleotide sequences
of the P gene were also submitted to MEGA4 and a tree was created
using the same method. GroupScan Analysis in the Simmonic
software package was used to plot the recombinant constitution of
W29 along with other five related sequences (window=200,
step=50). TreeOrderScan was also carried out in Simmonic with
genotype I sequences included as an individual group and the
output data were grouped and plotted as previous publication [18].
HBV 1.35-Fold Genome Plasmid Constructs
A 1.35-fold-overlength genome of HBV was constructed via
overlap extension PCRs and inserted into a CMV-promoter-
deleted pcDNA3.1 vector (Invitrogen, Shanghai, China, digested
by Spe I endonuclease). The genome had a 59 terminal
redundancy starting at 2961 nt and a 39 terminal end at
+2000 nt, including the entire polyadenylation site. The body of
the genome included Enh I and II, the X- and pregenomic/core
promoter regions, and the origin of replication (DR I and II). All
five clones of genotypes A, B, C and D were submitted to
GroupScan to evaluate the genotype representative before they
were annealed into plasmid constructs. Each HBV 1.35-fold
genome clone was confirmed by DNA sequencing.
Cell Culture and In Vitro Transfection
The plasmids used for in vitro transfection were purified with
PlasmidSelect Xtra Starter Kit (GE health, Sweden) and the
Evidence of HBV Genotype I
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od. After 24 hours of culture, Huh7 cells were transfected with
5 mg of DNA construct using Lipofectamine 2000 (GBICO, USA)
and harvested 4 days later. Transfection efficiency was measured
by cotransfection with 0.1 mg of a reporter plasmid expressing
secreted alkaline phosphatase (SEAP) and estimating SEAP
enzymatic activity in the culture supernatant. Triple experiments
were conducted for each clone.
Hydrodynamic Injection of Plasmid to Mice
To compare the in vivo HBV marker levels in different
genotypes, an HBV hydrodynamic injection assay was conducted
using 6–8 weeks old BALB/C mice. In brief, 40 mg of purified
plasmid was diluted to 2 mL with physiological saline and injected
into tail vein within 5–10 s. Mice sera were assayed for HBsAg and
HBeAg at 0,9 days after injection. For each group, five mice were
used. All animals received humane care and the study protocol is
complied with the institution’s guidelines.
Determination of HBV Markers in the Culture
Supernatant and Mouse Serum
HBsAg, HBeAg and HBcAg levels were determined by
chemiluminescence using commercial assay kits (Wantai, Beijing,
China). The relative level of each antigen was expressed as an
S/CO ratio, on a linear range from 1 to 1000 for all three assays.
The lower detection limit was 10pg/ml for the HBsAg and HBeAg
assays, and 50 pg/ml for the HBcAg. For extracellular HBV DNA
assay, the collected supernatant was treated with 200 mg/mL
DNase I and 100 mg/mL RNase A at 37uC for 2 hours, with
reaction terminated by EDTA at a final concentration of 10 mM.
Figure 1. Phylogenetic analysis of complete genomes (left) and P gene products (right). The sequences include all the reference
sequences, representative Vietnam and Laos’ sequence and W29 strains. The putative genotype I strains are separated as an independent clade.
Sequences of Genotype A-H have been collapsed into black triangles.
doi:10.1371/journal.pone.0009297.g001
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DNA was extracted using QIAamp DNA blood kits (QIAGEN,
Hilden, Germany). HBV DNA quantification assays were
performed using a commercial real-time PCR kit (Kehua,
Shanghai, China).
Nucleotide Sequence Accession Numbers
The nucleotide sequence data reported in this paper will appear
in the DDBJ/EMBL/GenBank databases under the accession
AY707087 N10 Ae, GU357842 C4371 Ba, GU357845 Y1021 C1,
GU357846 Y10 D1, and GU357844 W29 I1.
Results
W29 Is More Related to the Putative New Genotype I
Group
Leaving out W29, the other four strains can be clearly identified
as Genotype A, B, C and D (Data not shown). Phylogenetic trees
were generated using complete genomes and amino acid
sequences of P gene products, and both trees show that W29
falls within the same sequence clade as the Vietnam and Laos
strains, with this clade being separated from genotype C groups
(Fig. 1). The suggestion that this clade is a new genotype of HBV is
still under dispute [17,20,22]. In the tree of P gene, the clade
seems more related to genotype A than genotype C. Treating the
new genotype as genotype I, the grouping of W29 with Vietnam
and Laos’ sequence was confirmed by distance calculation (Fig. 2).
Distance values between the I group and other genotypes are no less
than 0.08, and the distance between W29 and I group is only
0.033 which is close to intra-genotype distance values. Further-
more, the distance between I group and genotype A/C (,0.08) is
smaller than other groups, which is consistent with the
phylogenetic tree result.
Recombination Analysis of W29 and Other Related
Sequences
A recombination analysis method based on stepwise phyloge-
netic tree construction using the programs SEQBOOT, DNA-
DIST, NEIGHBOR, and CONSENSE in the Phylip package was
first brought out by Simmonds, 2005 [18]. Two sequences
(AY236161 and AF461043) were used to evaluate the effectiveness
of the reference groups derived from all HBV sequences we
collected from GenBank up to April 2009. Changes in genotype
grouping, potentially arising from recombination, are character-
ized by abrupt changes in grouping scores of the sequence, as
shown for AY236161 and AF461043. The curvilinear trend on the
plots was almost the same as the plots reported [18] before.
Because GroupScan calculation is time consuming, nearly all of
the available HBV sequences have been submitted to GroupScan
and the results were collected as a database for web service
(available at http://nidvd.xmu.edu.cn/qgenotype). The service
includes GenBank ID query and a BLAST query based on NCBI
BLAST technology, and the recombination plots can be loaded
immediately via the two query methods without online phyloge-
netic calculation. For W29 the sequence, the curve attributed to
genotype C occupies the most regions from 1600 to 3000.
However, the first half of the sequence matches none of the human
or ape HBV genotypes, and lacking a group score greater than 0.5
indicating an outgroup position and exhibiting no phylogenetic
clustering with any reference group. In addition, the plots of
Vietnamese and Laotian strains’ sequences show almost the same
behavior, except for a subtle difference of genotype composition in
the first half of the sequence (Fig. 3). When composing the
reference sequences, a distinct sequence (EU833891) submitted
from Canada (unpublished) was found to have the same behavior
as the I group, and this strains was also selected in our later analysis.
To figure out the evolution relationship of these Vietnam strains
and genotype C strains, TreeOrderScan was also conducted using
all the above sequences. The distribution of different genotype
clades in the tree order map is not exactly the same as the
published result [18] mainly due to the initial group order and
different quantity of reference genotype sequences, but the relative
position and boundary indication of different genotypes clade is
similar (Fig. 4). On the tree order map, there is no evidence
showing any direct evolutionary relationship between the I group
and genotype C strains except the last 600 bp embedded in
genotype C clade.
Amino Acid Comparisons of Different Genotypes and
Subtypes
Fig. 5 lists the consensus amino acid sequence of all four HBV
genome products of different genotypes and subtypes with identical
columns excluded. Most of the 8 genotypes have severalunique sites
deduced from consensus sequences of various genotypes or
subtypes. Genotype-specific amino acids scattered along all four
gene products, and it seems that the space region of the P gene
Figure 2. Mean distances between full-length sequence of genotype A-H, genotype chimpanzee (Chi) and genotype I, generated by
MEGA4 package. Values on the diagonal are the mean distances within each genotype. The calculation is based on the Maximum Composite
Likelihood distance correction method.
doi:10.1371/journal.pone.0009297.g002
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PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9297Figure 3. Group Scan Analysis. Eight HBV strains were submitted to Group Scan program and calculated against the reference groups of
nonrecombinant HBV sequences from human genotypes A to H and nonhuman ape-derived variants (n=322) [18].
doi:10.1371/journal.pone.0009297.g003
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were also found in all five clones in our study. In the putative
genotype I, 5 unique sites (S207, K269, R270, S639, F/C823) were
found in the P gene, 2 unique sites (V48,L87) in the X gene, and 1
uniquesite (N87)inthepreSgene.GenotypeCshowsonly2 distinct
sites among all genome products whereas others have dozens.
Phenotypic Characteristics of W29 Strain In Vitro and In
Vivo
Five HBV 1.35-fold genome plasmids - N10 (Ae), C4371 (Ba),
Y1021 (C1), Y10 (D1), W29 (I1) – all of which existed in different
regions of China, were constructed for transfection and hydrody-
namic injection. None of these genomes possessed mutations for
G1896A in the precore region or A1762T/G1764A in the basic
core promoter, which may interfere with the expression of HBeAg
and the efficiency of pregenome encapsulation for replication. All
five strains had detectable levels of HBsAg, HBeAg, HBcAg and
HBV DNA in their transfected supernatants. The W29 (I1) and
N10 (Ae) strains had a similar, significantly lower HBeAg
expression level (P,0.01) than C4371 (Ba), Y1021 (C1) and Y10
(D1) in both of the Huh7 cellsand mice (Fig. 6). With regard to the
HBsAg secretion, W29 (I1) had a similar level with N10 (Ae),
C4371 (Ba) and Y1021 (C1), was and they were significant higher
than Y10 (D1). In addition, all five species show similar peak
HBsAg levels in mice serum. HBV DNA level and HBcAg levels in
Huh7 cells exhibit no significant difference between the five
strains. From an overview of the the results, the viral markers of
W29 (I1) in Huh7 cells and mice had a similar level with N10 (Ae)
but not Y1021 (C1), although it was more close to Y1021 (C1) in
distance analysis.
Discussion
This study includes almost all of the HBV sequences available
from GenBank. The GroupScan results of two test sequences
(AY236161 and AF461043) confirm that the selected reference
sequences are representative and maximally informative phyloge-
netically. The plot for AB231908 is also the same as the previously
published result [22], although we used a higher incrementing
steps value. When composing the reference sequence dataset,
nearly all of the HBV sequences available had been submitted to
the GroupScan analysis and corresponding recombination plots
generated. Besides one sequence reported from Canada, no other
sequence was found to have the same behavior as the Vietnamese
and Laotian sequences. Furthermore, these sequences fell into the
same clade on both trees; one generated using the complete
nucleotide sequence and the other using only P gene sequence. It
can be clearly observed on these two trees that group I sequences
respectively related to genotype A and C. This probably means
that we’d better categorize group I sequences into an independent
group distinct from any other known genotype than only as a
Figure 4. TreeOrder Scan of nonrecombinant HBV sequences. It shows positions of individual sequences (y axis) in phylogenetic trees
generated from sequential 250-base sequence fragments, incrementing by 25 bases (midpoints indicated in x axis). Changes in sequence orders
resulting from changes in phylogeny at the 70% bootstrap level are shown. Sequences are color coded by genotype, as indicated by labels in left
margins: genotype A, red; B, green; C, yellow; D, blue; E, purple; F, pink; G, pale yellow; H, brown; chimpanzee (Ch), light blue; woolly monkey
(outgroup on line 1), black. The boundaries of sequence groupings with 70% or greater bootstrap support are indicated with black horizontal lines;
for clarity, only clades between genotypes (except for group I) and with six or more members were demarcated. For comparison, the TreeOrder Scan
was aligned with a scale genome diagram of HBV (upper panel).
doi:10.1371/journal.pone.0009297.g004
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regions of these sequences may not be attributed to the genotype C
group. Using the limited SIMPLOT method, it had been proposed
that the putative genotype I is a recombinant of A/C/G [20], but
this conclusion was not supported by the newly developed method
of GroupScan, which overcomes the limitation of SIMPLOT. In
the recombination plot of W29, Vietnamese and Laotian strains,
the group score of genotype A could be detected at a lower value
(,0.5) in the region 1–1200 nt, but that is not sufficient evidence
to conclude that this part of the genome may bury in the genotype
A clade. In actuality, none of the known genotypes could be
matched to this region of W29.
Generally, HBV genotype C includes several serotypes: adrq+,
adrq2, ayr, adw, adw2, ayw2, ayw3, adwr [23]. We have checked all
available group I sequences and found that all of them contain K
or R on residue 122, K on residue 160 and P on residue 127. Thus
the serotypes of group I may be narrowed down to adw2 or ayw2.
In genotype C strains, serotype adw2 prevails in East Asia, Japan,
and the Philippines and ayw2 was only found in some Tibet strains
in China [23]. It has been proposed by Muller that the group I
sequences could be divided into two subgroups named I1 and I2
[17] and the divergence is also obvious in both phylogenetic trees
generated in this study. Boundaries among group I in the tree
order map (Fig. 4) were also retained to exhibit the divergence
Figure 5. Consensus amino acid sequences of 4 gene products of HBV (P, S, X and Pre-core/core) were arrayed according to
genotypes and subtypes, with identical columns excluded. Consensus sequences were derived from the 322 reference sequences. For page
view limited, unique sites in subtype were also omitted and the sequence number of amino acids was indicated alternately on the top and bottom of
the aligned matrix. Genotype-specific amino acids were highlighted with different colors and subtype-specific amino acids were only displayed in
corresponding colored letters.
doi:10.1371/journal.pone.0009297.g005
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I1 group falls into serotype adw2 and the I2 group into serotype
ayw2, without exception. As a result, the 122K/R could be
employed as an identifier to distinguish the two subgroups.
It is well accepted that the expression level of HBV markers vary
in different genotypes. In our cell culture results, secretion of
HBsAg is uniform abundant in all genotype except genotype D,
which agrees with the previous report [24]. But HBeAg expression
is entirely different. W29 exhibits a lower secretion of HBeAg, at a
level closest to genotype A, and much lower than that of genotype
B/C or D. Corroborating results were also observed in the acute
hydrodynamic injection mouse model, where HBsAg levels for all
5 genotypes were similar. It is the first report on HBsAg assay
comparing genotype I with other genotype, the differences in
HBsAg expression may be related to genotype specific differences
in sensitivity. All five strains were submitted to GroupScan and the
recombination plots generated were typical and representative of
the known genotypes A to D (Data not shown). The 8 genotype-
specific amino acids found on group I might contribute to their
distinct characterization in in vitro and in vivo marker assay, causing
5 unique mutations located on polymerase related protein.
Although the criteria of genotype differentiation do not include
phenotype differences, the distinct phenotype of group I indicates
an inevitable distance from genotype C.
It had been proposed for years that some strains from Vietnam
and Laos might be grouped into a new genotype of HBV [7,17].
However, the proposal is not yet widely accepted, because their
sequences deviate less than 8% from genotype C [22]. The
Figure 6. Comparison of expression levels of HBV markers between different genotypes in vitro and in vivo. Fig. a, b, c, d: HBsAg,
HBeAg, HBV DNA and HBcAg levels in Huh7 cell culture supernatant. SEAP reporter plasmid was co-transfected with each HBV plasmid as an internal
control. The SEAP activity of the first group (transfected with N10 (Ae) plasmid) was set as 1.0 and served as a reference, and the other groups were
calculated as relative SEAP activity. The presented data are a ratio of actual value to the relative SEAP activity value. Fig. e, f: Dynamic curve of HBsAg
and HBeAg expression levels in serums of hydrodynamic-injected mice. For each HBV plasmid, five mice were repeated. Due to the limited serum
resources, each sample was diluted 10-fold for mensuration.
doi:10.1371/journal.pone.0009297.g006
Evidence of HBV Genotype I
PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9297discovery of W29 expands the geographic distribution of this
special group, as the original host lives in the northwest of China,
and has never left the country. In addition, the EU833891 strains
may also represent a new geography distribution. Phylogenetic
analysis clearly show that W29 is most related to the putative
genotype I. The average distance value between W29 and
genotype C reach 8.4%, suggesting that W29 may represent a
more distant clade from genotype C than the Vietnamese and
Laotian strains do. When W29 was added to the presumed
genotype I group, the average distance between genotype I and C
is still as high as 8.0%, which just satisfies the well accepted criteria
for definition of a new genotype. Using the GroupScan and
TreeOrderScan methods developed by Simmond, we can
conclude that the last half of the group I genome is only a partial
analogue of genotype C’s genome, and that the majority of the
genome does not match any of the known HBV genotypes. In
addition, the phenotypic characteristic of W29, which might also
exist in Vietnamese and Laotian strains, account for the great
disparity between genotype C and the putative genotype I. All
things considered, this separate group of HBV strains might not be
simply reduced to a regional or recombinant mutation, and the
extending geographic distribution suggests that this group may
have existed for a long time. Just before this article was submitted,
another strain (FJ667206, partial genome) from France was
reported as being clustered with the genotype I [25]. A suggested
criterion raised by Schaefer also agreed to group these variants
into a new genotype [26]. We believe that in the future, more
strains will be discovered and add to this emerging new genotype.
Author Contributions
Conceived and designed the experiments: HY QY JZ PJC NSX.
Performed the experiments: HY QY YLZ QRC. Analyzed the data: HY
QY SXG HYW. Wrote the paper: HY QY.
References
1. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, et al. (1988)
Typing hepatitis B virus by homology in nucleotide sequence: comparison of
surface antigen subtypes. J Gen Virol 69 (Pt 10): 2575–2583.
2. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, et al. (2008)
Relationship of serological subtype, basic core promoter and precore mutations
to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80: 27–46.
3. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004)
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes,
subgenotypes, and HBsAg subtypes. Intervirology 47: 289–309.
4. Norder H, Courouce AM, Magnius LO (1994) Complete genomes, phylogenetic
relatedness, and structural proteins of six strains of the hepatitis B virus, four of
which represent two new genotypes. Virology 198: 489–503.
5. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, et al. (2000) A new
genotype of hepatitis B virus: complete genome and phylogenetic relatedness.
J Gen Virol 81: 67–74.
6. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a
new Amerindian genotype of hepatitis B virus revealed in Central America.
J Gen Virol 83: 2059–2073.
7. Hannoun C, Norder H, Lindh M (2000) An aberrant genotype revealed in
recombinant hepatitis B virus strains from Vietnam. J Gen Virol 81: 2267–2272.
8. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, et al. (2009) A
genetic variant of hepatitis B virus divergent from known human and ape
genotypes isolated from a Japanese patient and provisionally assigned to new
genotype J. J Virol 83: 10538–10547.
9. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, et al. (1987) Point
mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in
two blood donors carrying a surface antigen of compound subtype adyr or adwr.
J Virol 61: 3030–3034.
10. Norder H, Courouce AM, Magnius LO (1992) Molecular basis of hepatitis B
virus serotype variations within the four major subtypes. J Gen Virol 73 (Pt 12):
3141–3145.
11. Schaefer S (2005) Hepatitis B virus: significance of genotypes. J Viral Hepat 12:
111–124.
12. Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in
Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad
Sci U S A 84: 1005–1009.
13. Gerber MA, Sells MA, Chen ML, Thung SN, Tabibzadeh SS, et al. (1988)
Morphologic, immunohistochemical, and ultrastructural studies of the produc-
tion of hepatitis B virus in vitro. Lab Invest 59: 173–180.
14. Acs G, Sells MA, Purcell RH, Price P, Engle R, et al. (1987) Hepatitis B virus
produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl
Acad Sci U S A 84: 4641–4644.
15. Yang PL, Althage A, Chung J, Chisari FV (2002) Hydrodynamic injection of
viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad
Sci U S A 99: 13825–13830.
16. Huang LR, Wu HL, Chen PJ, Chen DS (2006) An immunocompetent mouse
model for the tolerance of human chronic hepatitis B virus infection. Proc Natl
Acad Sci U S A 103: 17862–17867.
17. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, et al.
(2008) Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis
14: 1777–1780.
18. Simmonds P, Midgley S (2005) Recombination in the genesis and evolution of
hepatitis B virus genotypes. J Virol 79: 15467–15476.
19. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, et al. (1995) A novel method
for efficient amplification of whole hepatitis B virus genomes permits rapid
functional analysis and reveals deletion mutants in immunosuppressed patients.
J Virol 69: 5437–5444.
20. Tran TT, Trinh TN, Abe K (2008) New complex recombinant genotype of
hepatitis B virus identified in Vietnam. J Virol 82: 5657–5663.
21. Kumar S, Nei M, Dudley J, Tamura K (2008) MEGA: a biologist-centric
software for evolutionary analysis of DNA and protein sequences. Brief
Bioinform 9: 299–306.
22. Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M (2008) When
should ‘‘I’’ consider a new hepatitis B virus genotype? J Virol 82: 8241–8242.
23. Kramvis A, Kew M, Francois G (2005) Hepatitis B virus genotypes. Vaccine 23:
2409–2423.
24. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, et al. (2006) Influence of
hepatitis B virus genotypes on the intra- and extracellular expression of viral
DNA and antigens. Hepatology 44: 915–924.
25. Colson P, Roquelaure B, Tamalet C (2009) Detection of a newly identified
hepatitis B virus genotype in southeastern France. J Clin Virol 45: 165–167.
26. Schaefer S, Magnius L, Norder H (2009) Under construction: classification of
hepatitis B virus genotypes and subgenotypes. Intervirology 52: 323–325.
Evidence of HBV Genotype I
PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9297